An acetyl-Lys174 antibody, raised against Tau acetylated at Lys174, did not immunoreact with any of the samples tested, including human brain extracts from late-stage AD donors, where Tau acetylation at Lys174 has been previously reported [105] (Supp. The gene discussed is MAPT; the disease is Alzheimer disease.